T0	Participants 59 71	adolescents.
T1	Participants 160 244	hypertensive adolescents requiring pharmacologic therapy for blood pressure control.
T2	Participants 245 341	Twenty-four adolescents with persistent blood pressure elevation (greater than 95th%) on placebo